Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 1863 entries
View as:

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00587964 Org: User:
Start: 06/30/04 End: 01/31/09 Due: 01/31/10

Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

Phase: N/A Priority: Normal
NCT ID: NCT02199236 Org: User:
Start: 07/31/14 End: 10/29/24 Due: 10/29/25

Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02633137 Org: User:
Start: 12/14/15 End: 11/07/23 Due: 11/07/24

Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00022256 Org: User:
Start: 04/30/01 End: 04/30/03 Due: 04/30/04

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Phase: N/A Priority: Normal
NCT ID: NCT01418001 Org: User:
Start: 08/31/11 End: 11/30/15 Due: 11/30/16

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

Phase: N/A Priority: Normal
NCT ID: NCT05489783 Org: User:
Start: 07/29/22 End: 07/29/25 Due: 07/29/26

High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00604526 Org: User:
Start: 09/30/06 End: 12/31/14 Due: 12/31/15

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

Phase: N/A Priority: Normal
NCT ID: NCT01604512 Org: User:
Start: 05/31/12 End: 12/29/23 Due: 12/29/24

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

Phase: N/A Priority: Normal
NCT ID: NCT01639508 Org: User:
Start: 07/31/12 End: 07/31/26 Due: 07/31/27

A Study of Hospital-at-Home for People Receiving Tarlatamab

Phase: N/A Priority: Normal
NCT ID: NCT06957314 Org: User:
Start: 04/23/25 End: 04/23/28 Due: 04/23/29

Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life

Phase: N/A Priority: Normal
NCT ID: NCT01134172 Org: User:
Start: 05/31/10 End: 05/31/26 Due: 05/31/27

Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

Phase: N/A Priority: Normal
NCT ID: NCT01248273 Org: User:
Start: 11/30/10 End: 03/31/17 Due: 03/31/18

TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02764333 Org: User:
Start: 05/06/16 End: 01/20/21 Due: 01/20/22

Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL

Phase: N/A Priority: Normal
NCT ID: NCT00588094 Org: User:
Start: 10/31/03 End: 03/31/10 Due: 03/31/11

Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00027716 Org: User:
Start: 10/31/01 End: 05/31/04 Due: 05/31/05

Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00004245 Org: User:
Start: 08/31/99 End: - Due: -

Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00773773 Org: User:
Start: 10/14/08 End: 03/08/24 Due: 03/08/25

The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT01423734 Org: User:
Start: 08/23/11 End: 01/19/23 Due: 01/19/24

Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00595725 Org: User:
Start: 02/28/03 End: 09/30/11 Due: 09/30/12

Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00582920 Org: User:
Start: 01/31/06 End: 10/31/08 Due: 10/31/09

Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01104350 Org: User:
Start: 04/30/10 End: 04/30/26 Due: 04/30/27

IFACT: Incidental Findings in Advanced Cancer Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02217891 Org: User:
Start: 08/31/14 End: 02/09/23 Due: 02/09/24

Choosing Options for Insomnia in Cancer Effectively (CHOICE): A Comparative Effectiveness Trial of Acupuncture and Cognitive Behavior Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02356575 Org: User:
Start: 02/28/15 End: 07/31/17 Due: 07/31/18

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

Phase: N/A Priority: Normal
NCT ID: NCT01892397 Org: User:
Start: 06/30/13 End: 06/30/25 Due: 06/30/26

Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01973452 Org: User:
Start: 10/31/13 End: 12/22/22 Due: 12/22/23